Andrew K. Godwin - Publications

Biochemistry and Molecular Biology Drexel University College of Medicine, Philadelphia, PA, United States 
Molecular Biology, Biostatistics Biology

261 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Peri S, Caretti E, Tricarico R, Devarajan K, Cheung M, Sementino E, Menges CW, Nicolas E, Vanderveer LA, Howard S, Conrad P, Crowell JA, Campbell KS, Ross EA, Godwin AK, et al. Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation. Oncotarget. PMID 27682873 DOI: 10.18632/Oncotarget.12192  0.56
2016 Serrero G, Hawkins DM, Bejarano PA, Ioffe O, Tkaczuk KR, Elliott RE, Head JF, Phillips J, Godwin AK, Weaver J, Hicks D, Yue B. Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index. Diagnostic Pathology. 11: 71. PMID 27501955 DOI: 10.1186/S13000-016-0520-4  0.76
2016 Wang Y, Cai KQ, Smith ER, Yeasky TM, Moore R, Ganjei-Azar P, Klein-Szanto AJ, Godwin AK, Hamilton TC, Xu XX. Follicle Depletion Provides A Permissive Environment for Ovarian Carcinogenesis. Molecular and Cellular Biology. PMID 27354067 DOI: 10.1128/Mcb.00202-16  0.76
2015 Belinsky MG, Rink L, Cai KQ, Capuzzi SJ, Hoang Y, Chien J, Godwin AK, von Mehren M. Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case. Bmc Cancer. 15: 887. PMID 26555092 DOI: 10.1186/s12885-015-1872-y  0.76
2015 Elsarraj HS, Hong Y, Valdez KE, Michaels W, Hook M, Smith WP, Chien J, Herschkowitz JI, Troester MA, Beck M, Inciardi M, Gatewood J, May L, Cusick T, McGinness M, ... ... Godwin AK, et al. Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion. Breast Cancer Research : Bcr. 17: 128. PMID 26384318 DOI: 10.1186/S13058-015-0630-Z  0.76
2015 Graw S, Meier R, Minn K, Bloomer C, Godwin AK, Fridley B, Vlad A, Beyerlein P, Chien J. Robust gene expression and mutation analyses of RNA-sequencing of formalin-fixed diagnostic tumor samples. Scientific Reports. 5: 12335. PMID 26202458 DOI: 10.1038/Srep12335  0.76
2015 Alturkmani HJ, Pessetto ZY, Godwin AK. Beyond standard therapy: drugs under investigation for the treatment of gastrointestinal stromal tumor. Expert Opinion On Investigational Drugs. 24: 1045-58. PMID 26098203 DOI: 10.1517/13543784.2015.1046594  0.76
2015 Blein S, Bardel C, Danjean V, McGuffog L, Healey S, Barrowdale D, Lee A, Dennis J, Kuchenbaecker KB, Soucy P, Terry MB, Chung WK, Goldgar DE, Buys SS, ... ... Godwin AK, et al. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers. Breast Cancer Research : Bcr. 17: 61. PMID 25925750 DOI: 10.1186/S13058-015-0567-2  0.76
2015 Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, Mazoyer S, Chenevix-Trench G, Easton DF, Antoniou AC, Nathanson KL, Laitman Y, Kushnir A, Paluch-Shimon S, ... ... Godwin AK, et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. Jama. 313: 1347-61. PMID 25849179 DOI: 10.1001/Jama.2014.5985  0.76
2015 Marks JR, Anderson KS, Engstrom P, Godwin AK, Esserman LJ, Longton G, Iversen ES, Mathew A, Patriotis C, Pepe MS. Construction and analysis of the NCI-EDRN breast cancer reference set for circulating markers of disease. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 435-41. PMID 25471344 DOI: 10.1158/1055-9965.Epi-14-1178  0.76
2015 Couch FJ, Hart SN, Sharma P, Toland AE, Wang X, Miron P, Olson JE, Godwin AK, Pankratz VS, Olswold C, Slettedahl S, Hallberg E, Guidugli L, Davila JI, Beckmann MW, et al. Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 304-11. PMID 25452441 DOI: 10.1200/Jco.2014.57.1414  0.76
2015 Kwon Y, Smith BD, Zhou Y, Kaufman MD, Godwin AK. Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment. Oncogene. 34: 144-53. PMID 24362531 DOI: 10.1038/Onc.2013.539  0.76
2014 Spurdle AB, Couch FJ, Parsons MT, McGuffog L, Barrowdale D, Bolla MK, Wang Q, Healey S, Schmutzler R, Wappenschmidt B, Rhiem K, Hahnen E, Engel C, Meindl A, Ditsch N, ... ... Godwin AK, et al. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Research : Bcr. 16: 3419. PMID 25857409 DOI: 10.1186/S13058-014-0474-Y  0.76
2014 Zhang X, Cheng L, Minn K, Madan R, Godwin AK, Shridhar V, Chien J. Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cells. Oncotarget. 5: 11365-80. PMID 25426548  0.76
2014 Pessetto ZY, Ma Y, Hirst JJ, von Mehren M, Weir SJ, Godwin AK. Drug repurposing identifies a synergistic combination therapy with imatinib mesylate for gastrointestinal stromal tumor. Molecular Cancer Therapeutics. 13: 2276-87. PMID 25122069 DOI: 10.1158/1535-7163.MCT-14-0043  0.76
2014 He M, Crow J, Roth M, Zeng Y, Godwin AK. Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology. Lab On a Chip. 14: 3773-80. PMID 25099143 DOI: 10.1039/C4Lc00662C  0.76
2014 Fang CY, Ross EA, Pathak HB, Godwin AK, Tseng M. Acculturative stress and inflammation among Chinese immigrant women. Psychosomatic Medicine. 76: 320-6. PMID 24846001 DOI: 10.1097/PSY.0000000000000065  0.76
2014 Sharma P, Klemp JR, Kimler BF, Mahnken JD, Geier LJ, Khan QJ, Elia M, Connor CS, McGinness MK, Mammen JM, Wagner JL, Ward C, Ranallo L, Knight CJ, Stecklein SR, ... ... Godwin AK, et al. Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing. Breast Cancer Research and Treatment. 145: 707-14. PMID 24807107 DOI: 10.1007/S10549-014-2980-0  0.76
2014 Atay S, Godwin AK. Tumor-derived exosomes: A message delivery system for tumor progression. Communicative & Integrative Biology. 7: e28231. PMID 24778765 DOI: 10.4161/cib.28231  0.76
2014 Hensley H, Devarajan K, Johnson JR, Piwnica-Worms D, Godwin AK, von Mehren M, Rink L. Evaluating new therapies in gastrointestinal stromal tumor using in vivo molecular optical imaging. Cancer Biology & Therapy. 15: 911-8. PMID 24755645 DOI: 10.4161/Cbt.28880  0.76
2014 Fridley BL, Koestler DC, Koeslter DC, Godwin AK. Individualizing care for ovarian cancer patients using big data. Journal of the National Cancer Institute. 106. PMID 24700802 DOI: 10.1093/Jnci/Dju080  0.76
2014 Osorio A, Milne RL, Kuchenbaecker K, Vaclová T, Pita G, Alonso R, Peterlongo P, Blanco I, de la Hoya M, Duran M, Díez O, Ramón Y Cajal T, Konstantopoulou I, Martínez-Bouzas C, Andrés Conejero R, ... ... Godwin AK, et al. DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers. Plos Genetics. 10: e1004256. PMID 24698998 DOI: 10.1371/Journal.Pgen.1004256  0.76
2014 Gao W, Ma GX, Tan Y, Fang C, Weaver J, Jin M, Lai P, Godwin AK. Culturally appropriate education intervention on biospecimen research participation among Chinese Americans. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 383-91. PMID 24609847 DOI: 10.1158/1055-9965.EPI-13-0742  0.76
2014 Atay S, Banskota S, Crow J, Sethi G, Rink L, Godwin AK. Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion. Proceedings of the National Academy of Sciences of the United States of America. 111: 711-6. PMID 24379393 DOI: 10.1073/Pnas.1310501111  0.76
2014 Kruger TE, Miller AH, Godwin AK, Wang J. Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers. Critical Reviews in Oncology/Hematology. 89: 330-41. PMID 24071501 DOI: 10.1016/j.critrevonc.2013.08.013  0.76
2014 Price JC, Pollock LM, Rudd ML, Fogoros SK, Mohamed H, Hanigan CL, Le Gallo M, Program NI, Zhang S, Cruz P, Cherukuri PF, Hansen NF, McManus KJ, Godwin AK, Sgroi DC, et al. Sequencing of candidate chromosome instability genes in endometrial cancers reveals somatic mutations in ESCO1, CHTF18, and MRE11A. Plos One. 8: e63313. PMID 23755103 DOI: 10.1371/Journal.Pone.0063313  0.76
2014 Do TV, Xiao F, Bickel LE, Klein-Szanto AJ, Pathak HB, Hua X, Howe C, O'Brien SW, Maglaty M, Ecsedy JA, Litwin S, Golemis EA, Schilder RJ, Godwin AK, Connolly DC. Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion. Oncogene. 33: 539-49. PMID 23334327 DOI: 10.1038/Onc.2012.632  0.76
2013 Yew KH, Crow J, Hirst J, Pessetto Z, Pressetto Z, Godwin AK. Epimorphin-induced MET sensitizes ovarian cancer cells to platinum. Plos One. 8: e72637. PMID 24039787 DOI: 10.1371/journal.pone.0072637  0.76
2013 Pessetto ZY, Weir SJ, Sethi G, Broward MA, Godwin AK. Drug repurposing for gastrointestinal stromal tumor. Molecular Cancer Therapeutics. 12: 1299-309. PMID 23657945 DOI: 10.1158/1535-7163.Mct-12-0968  0.76
2013 Couch FJ, Wang X, McGuffog L, Lee A, Olswold C, Kuchenbaecker KB, Soucy P, Fredericksen Z, Barrowdale D, Dennis J, Gaudet MM, Dicks E, Kosel M, Healey S, Sinilnikova OM, ... ... Godwin AK, et al. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. Plos Genetics. 9: e1003212. PMID 23544013 DOI: 10.1371/Journal.Pgen.1003212  0.76
2013 Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK, Brook MN, Orr N, Rhie SK, Riboli E, Feigelson HS, Le Marchand L, Buring JE, Eccles D, Miron P, Fasching PA, ... ... Godwin AK, et al. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nature Genetics. 45: 392-8, 398e1-2. PMID 23535733 DOI: 10.1038/Ng.2561  0.76
2013 Leslie KK, Sill MW, Fischer E, Darcy KM, Mannel RS, Tewari KS, Hanjani P, Wilken JA, Baron AT, Godwin AK, Schilder RJ, Singh M, Maihle NJ. A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: a Gynecologic Oncology Group study. Gynecologic Oncology. 129: 486-94. PMID 23438670 DOI: 10.1016/J.Ygyno.2013.02.019  0.76
2013 Rink L, Ochs MF, Zhou Y, von Mehren M, Godwin AK. ZNF-mediated resistance to imatinib mesylate in gastrointestinal stromal tumor. Plos One. 8: e54477. PMID 23372733 DOI: 10.1371/journal.pone.0054477  0.76
2013 Schilder RJ, Sill MW, Lankes HA, Gold MA, Mannel RS, Modesitt SC, Hanjani P, Bonebrake AJ, Sood AK, Godwin AK, Hu W, Alpaugh RK. A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: a Gynecologic Oncology Group study. Gynecologic Oncology. 129: 86-91. PMID 23321064 DOI: 10.1016/J.Ygyno.2013.01.006  0.76
2013 Belinsky MG, Rink L, Flieder DB, Jahromi MS, Schiffman JD, Godwin AK, Mehren Mv. Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors. Genes, Chromosomes & Cancer. 52: 214-24. PMID 23109135 DOI: 10.1002/gcc.22023  0.76
2013 Bernardo GM, Bebek G, Ginther CL, Sizemore ST, Lozada KL, Miedler JD, Anderson LA, Godwin AK, Abdul-Karim FW, Slamon DJ, Keri RA. FOXA1 represses the molecular phenotype of basal breast cancer cells. Oncogene. 32: 554-63. PMID 22391567 DOI: 10.1038/Onc.2012.62  0.76
2012 Le Gallo M, O'Hara AJ, Rudd ML, Urick ME, Hansen NF, O'Neil NJ, Price JC, Zhang S, England BM, Godwin AK, Sgroi DC, Hieter P, Mullikin JC, Merino MJ, et al. Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes. Nature Genetics. 44: 1310-5. PMID 23104009 DOI: 10.1038/Ng.2455  0.76
2012 Sethi G, Pathak HB, Zhang H, Zhou Y, Einarson MB, Vathipadiekal V, Gunewardena S, Birrer MJ, Godwin AK. An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer. Plos One. 7: e47086. PMID 23056589 DOI: 10.1371/Journal.Pone.0047086  0.76
2012 Stevens KN, Wang X, Fredericksen Z, Pankratz VS, Greene MH, Andrulis IL, Thomassen M, Caligo M, Nathanson KL, Jakubowska A, Osorio A, Hamann U, Godwin AK, Stoppa-Lyonnet D, et al. Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers. Breast Cancer Research and Treatment. 136: 295-302. PMID 23011509 DOI: 10.1007/S10549-012-2255-6  0.76
2012 Siddiq A, Couch FJ, Chen GK, Lindström S, Eccles D, Millikan RC, Michailidou K, Stram DO, Beckmann L, Rhie SK, Ambrosone CB, Aittomäki K, Amiano P, Apicella C, ... ... Godwin AK, et al. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Human Molecular Genetics. 21: 5373-84. PMID 22976474 DOI: 10.1093/Hmg/Dds381  0.76
2012 Guo S, Liu M, Godwin AK. Transcriptional regulation of hTREX84 in human cancer cells. Plos One. 7: e43610. PMID 22952718 DOI: 10.1371/journal.pone.0043610  0.76
2012 Coleman RL, Sill MW, Lankes HA, Fader AN, Finkler NJ, Hoffman JS, Rose PG, Sutton GP, Drescher CW, McMeekin DS, Hu W, Deavers M, Godwin AK, Alpaugh RK, Sood AK. A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study. Gynecologic Oncology. 127: 538-43. PMID 22922531 DOI: 10.1016/J.Ygyno.2012.08.020  0.76
2012 Leslie KK, Sill MW, Lankes HA, Fischer EG, Godwin AK, Gray H, Schilder RJ, Walker JL, Tewari K, Hanjani P, Abulafia O, Rose PG. Lapatinib and potential prognostic value of EGFR mutations in a Gynecologic Oncology Group phase II trial of persistent or recurrent endometrial cancer. Gynecologic Oncology. 127: 345-50. PMID 22885469 DOI: 10.1016/J.Ygyno.2012.07.127  0.76
2012 Brewster BL, Rossiello F, French JD, Edwards SL, Wong M, Wronski A, Whiley P, Waddell N, Chen X, Bove B, Hopper JL, John EM, Andrulis I, Daly M, ... ... Godwin AK, et al. Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site. Human Mutation. 33: 1665-75. PMID 22753153 DOI: 10.1002/Humu.22159  0.76
2012 Ding YC, McGuffog L, Healey S, Friedman E, Laitman Y, Paluch-Shimon S, Kaufman B, Liljegren A, Lindblom A, Olsson H, Kristoffersson U, Stenmark-Askmalm M, Melin B, Domchek SM, ... ... Godwin AK, et al. A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1362-70. PMID 22729394 DOI: 10.1158/1055-9965.Epi-12-0229  0.76
2012 Schilder RJ, Brady WE, Lankes HA, Fiorica JV, Shahin MS, Zhou XC, Mannel RS, Pathak HB, Hu W, Alpaugh RK, Sood AK, Godwin AK. Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecologic Oncology. 127: 70-4. PMID 22710075 DOI: 10.1016/j.ygyno.2012.06.009  0.76
2012 Maia AT, Antoniou AC, O'Reilly M, Samarajiwa S, Dunning M, Kartsonaki C, Chin SF, Curtis CN, McGuffog L, Domchek SM, Easton DF, Peock S, Frost D, Evans DG, ... ... Godwin AK, et al. Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers. Breast Cancer Research : Bcr. 14: R63. PMID 22513257 DOI: 10.1186/bcr3169  0.76
2012 Van den Abbeele AD, Gatsonis C, de Vries DJ, Melenevsky Y, Szot-Barnes A, Yap JT, Godwin AK, Rink L, Huang M, Blevins M, Sicks J, Eisenberg B, Siegel BA. ACRIN 6665/RTOG 0132 phase II trial of neoadjuvant imatinib mesylate for operable malignant gastrointestinal stromal tumor: monitoring with 18F-FDG PET and correlation with genotype and GLUT4 expression. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 567-74. PMID 22381410 DOI: 10.2967/Jnumed.111.094425  0.76
2012 Couch FJ, Gaudet MM, Antoniou AC, Ramus SJ, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, Wang X, Kirchhoff T, McGuffog L, Barrowdale D, Lee A, Healey S, Sinilnikova OM, ... ... Godwin AK, et al. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 645-57. PMID 22351618 DOI: 10.1158/1055-9965.Epi-11-0888  0.76
2012 Stevens KN, Fredericksen Z, Vachon CM, Wang X, Margolin S, Lindblom A, Nevanlinna H, Greco D, Aittomäki K, Blomqvist C, Chang-Claude J, Vrieling A, Flesch-Janys D, Sinn HP, Wang-Gohrke S, ... ... Godwin AK, et al. 19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Research. 72: 1795-803. PMID 22331459 DOI: 10.1158/0008-5472.Can-11-3364  0.76
2012 Serrero G, Hawkins DM, Yue B, Ioffe O, Bejarano P, Phillips JT, Head JF, Elliott RL, Tkaczuk KR, Godwin AK, Weaver J, Kim WE. Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma. Breast Cancer Research : Bcr. 14: R26. PMID 22316048 DOI: 10.1186/Bcr3111  0.76
2012 Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Karlan BY, Lambrechts D, Despierre E, Barrowdale D, McGuffog L, Healey S, Easton DF, Sinilnikova O, Benítez J, García MJ, ... ... Godwin AK, et al. Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. Jama. 307: 382-90. PMID 22274685 DOI: 10.1001/Jama.2012.20  0.76
2012 Dotan E, Meropol NJ, Zhu F, Zambito F, Bove B, Cai KQ, Godwin AK, Golemis EA, Astsaturov I, Cohen SJ. Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer. British Journal of Cancer. 106: 748-55. PMID 22240781 DOI: 10.1038/Bjc.2011.587  0.76
2012 Laitman Y, Kuchenbaecker KB, Rantala J, Hogervorst F, Peock S, Godwin AK, Arason A, Kirchhoff T, Offit K, Isaacs C, Schmutzler RK, Wappenschmidt B, Nevanlinna H, Chen X, Chenevix-Trench G, et al. The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. 132: 1119-26. PMID 22212556 DOI: 10.1007/S10549-011-1938-8  0.76
2012 Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, ... ... Godwin AK, et al. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 134-47. PMID 22144499 DOI: 10.1158/1055-9965.Epi-11-0775  0.76
2012 Garcia AA, Sill MW, Lankes HA, Godwin AK, Mannel RS, Armstrong DK, Carolla RL, Liepman MK, Spirtos NM, Fischer EG, Leslie KK. A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a gynecologic oncology group study. Gynecologic Oncology. 124: 569-74. PMID 22037316 DOI: 10.1016/J.Ygyno.2011.10.022  0.76
2012 Piccione EC, Lieu TJ, Gentile CF, Williams TR, Connolly AJ, Godwin AK, Koong AC, Wong AJ. A novel epidermal growth factor receptor variant lacking multiple domains directly activates transcription and is overexpressed in tumors. Oncogene. 31: 2953-67. PMID 21986942 DOI: 10.1038/Onc.2011.465  0.76
2012 Knouf EC, Garg K, Arroyo JD, Correa Y, Sarkar D, Parkin RK, Wurz K, O'Briant KC, Godwin AK, Urban ND, Ruzzo WL, Gentleman R, Drescher CW, Swisher EM, Tewari M. An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription. Nucleic Acids Research. 40: 499-510. PMID 21917857 DOI: 10.1093/Nar/Gkr731  0.76
2012 Ratushny V, Pathak HB, Beeharry N, Tikhmyanova N, Xiao F, Li T, Litwin S, Connolly DC, Yen TJ, Weiner LM, Godwin AK, Golemis EA. Dual inhibition of SRC and Aurora kinases induces postmitotic attachment defects and cell death. Oncogene. 31: 1217-27. PMID 21785464 DOI: 10.1038/Onc.2011.314  0.76
2011 Godwin AK. Bench to bedside and back again: personalizing treatment for patients with GIST. Molecular Cancer Therapeutics. 10: 2026-7. PMID 22072810 DOI: 10.1158/1535-7163.MCT-11-0709  0.76
2011 Mulligan AM, Couch FJ, Barrowdale D, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Robson M, Sherman M, Spurdle AB, Wappenschmidt B, Lee A, McGuffog L, Healey S, Sinilnikova OM, ... ... Godwin AK, et al. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Research : Bcr. 13: R110. PMID 22053997 DOI: 10.1186/Bcr3052  0.76
2011 Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, Millikan RC, Wang X, Ademuyiwa F, Ahmed S, Ambrosone CB, Baglietto L, Balleine R, Bandera EV, Beckmann MW, Berg CD, ... ... Godwin AK, et al. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nature Genetics. 43: 1210-4. PMID 22037553 DOI: 10.1038/Ng.985  0.76
2011 Bell DW, Sikdar N, Lee KY, Price JC, Chatterjee R, Park HD, Fox J, Ishiai M, Rudd ML, Pollock LM, Fogoros SK, Mohamed H, Hanigan CL, Zhang S, ... ... Godwin AK, et al. Predisposition to cancer caused by genetic and functional defects of mammalian Atad5. Plos Genetics. 7: e1002245. PMID 21901109 DOI: 10.1371/Journal.Pgen.1002245  0.76
2011 Cox DG, Simard J, Sinnett D, Hamdi Y, Soucy P, Ouimet M, Barjhoux L, Verny-Pierre C, McGuffog L, Healey S, Szabo C, Greene MH, Mai PL, Andrulis IL, ... ... Godwin AK, et al. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. Human Molecular Genetics. 20: 4732-47. PMID 21890493 DOI: 10.1093/Hmg/Ddr388  0.76
2011 Stevens KN, Vachon CM, Lee AM, Slager S, Lesnick T, Olswold C, Fasching PA, Miron P, Eccles D, Carpenter JE, Godwin AK, Ambrosone C, Winqvist R, Brauch H, et al. Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Research. 71: 6240-9. PMID 21844186 DOI: 10.1158/0008-5472.Can-11-1266  0.76
2011 Bitler BG, Nicodemus JP, Li H, Cai Q, Wu H, Hua X, Li T, Birrer MJ, Godwin AK, Cairns P, Zhang R. Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence. Cancer Research. 71: 6184-94. PMID 21816908 DOI: 10.1158/0008-5472.Can-11-1341  0.76
2011 Roussi P, Sherman KA, Miller SM, Hurley K, Daly MB, Godwin A, Buzaglo JS, Wen KY. Identification of cognitive profiles among women considering BRCA1/2 testing through the utilisation of cluster analytic techniques. Psychology & Health. 26: 1327-43. PMID 21756124 DOI: 10.1080/08870446.2010.521938  0.76
2011 Behbakht K, Sill MW, Darcy KM, Rubin SC, Mannel RS, Waggoner S, Schilder RJ, Cai KQ, Godwin AK, Alpaugh RK. Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study. Gynecologic Oncology. 123: 19-26. PMID 21752435 DOI: 10.1016/J.Ygyno.2011.06.022  0.76
2011 Shaw CM, Stanczyk FZ, Egleston BL, Kahle LL, Spittle CS, Godwin AK, Brinton LA, Dorgan JF. Serum antimüllerian hormone in healthy premenopausal women. Fertility and Sterility. 95: 2718-21. PMID 21704216 DOI: 10.1016/J.Fertnstert.2011.05.051  0.76
2011 Capo-chichi CD, Cai KQ, Smedberg J, Ganjei-Azar P, Godwin AK, Xu XX. Loss of A-type lamin expression compromises nuclear envelope integrity in breast cancer. Chinese Journal of Cancer. 30: 415-25. PMID 21627864 DOI: 10.5732/cjc.010.10566  0.76
2011 Sasaroli D, Gimotty PA, Pathak HB, Hammond R, Kougioumtzidou E, Katsaros D, Buckanovich R, Devarajan K, Sandaltzopoulos R, Godwin AK, Scholler N, Coukos G. Novel surface targets and serum biomarkers from the ovarian cancer vasculature. Cancer Biology & Therapy. 12: 169-80. PMID 21617380 DOI: 10.4161/Cbt.12.3.16260  0.76
2011 Huang J, Zhang L, Greshock J, Colligon TA, Wang Y, Ward R, Katsaros D, Lassus H, Butzow R, Godwin AK, Testa JR, Nathanson KL, Gimotty PA, Coukos G, Weber BL, et al. Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome. Genes, Chromosomes & Cancer. 50: 606-18. PMID 21563232 DOI: 10.1002/Gcc.20883  0.76
2011 Kanetsky PA, Mitra N, Vardhanabhuti S, Vaughn DJ, Li M, Ciosek SL, Letrero R, D'Andrea K, Vaddi M, Doody DR, Weaver J, Chen C, Starr JR, HÃ¥konarson H, Rader DJ, ... Godwin AK, et al. A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility. Human Molecular Genetics. 20: 3109-17. PMID 21551455 DOI: 10.1093/Hmg/Ddr207  0.76
2011 Kwon Y, Cukierman E, Godwin AK. Differential expressions of adhesive molecules and proteases define mechanisms of ovarian tumor cell matrix penetration/invasion. Plos One. 6: e18872. PMID 21526198 DOI: 10.1371/journal.pone.0018872  0.76
2011 Urick ME, Rudd ML, Godwin AK, Sgroi D, Merino M, Bell DW. PIK3R1 (p85α) is somatically mutated at high frequency in primary endometrial cancer. Cancer Research. 71: 4061-7. PMID 21478295 DOI: 10.1158/0008-5472.CAN-11-0549  0.76
2011 Wang X, Chow R, Deng L, Anderson D, Weidner N, Godwin AK, Bewtra C, Zlotnik A, Bui J, Varki A, Varki N. Expression of Siglec-11 by human and chimpanzee ovarian stromal cells, with uniquely human ligands: implications for human ovarian physiology and pathology. Glycobiology. 21: 1038-48. PMID 21467073 DOI: 10.1093/Glycob/Cwr039  0.76
2011 Capo-chichi CD, Cai KQ, Simpkins F, Ganjei-Azar P, Godwin AK, Xu XX. Nuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancer. Bmc Medicine. 9: 28. PMID 21439080 DOI: 10.1186/1741-7015-9-28  0.76
2011 Usha L, Sill MW, Darcy KM, Benbrook DM, Hurteau JA, Michelin DP, Mannel RS, Hanjani P, De Geest K, Godwin AK. A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies. Gynecologic Oncology. 121: 455-61. PMID 21414654 DOI: 10.1016/J.Ygyno.2011.02.013  0.76
2011 Pharoah PD, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS, Beckmann MW, Birrer MJ, Bogdanova N, Bolton KL, ... ... Godwin AK, et al. The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 3742-50. PMID 21385923 DOI: 10.1158/1078-0432.Ccr-10-3405  0.76
2011 Cramer DW, Bast RC, Berg CD, Diamandis EP, Godwin AK, Hartge P, Lokshin AE, Lu KH, McIntosh MW, Mor G, Patriotis C, Pinsky PF, Thornquist MD, Scholler N, Skates SJ, et al. Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prevention Research (Philadelphia, Pa.). 4: 365-74. PMID 21372036 DOI: 10.1158/1940-6207.Capr-10-0195  0.76
2011 Smith LD, Tesoriero AA, Wong EM, Ramus SJ, O'Malley FP, Mulligan AM, Terry MB, Senie RT, Santella RM, John EM, Andrulis IL, Ozcelik H, Daly MB, Godwin AK, Buys SS, et al. Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry. Breast Cancer Research : Bcr. 13: R14. PMID 21281505 DOI: 10.1186/Bcr2822  0.76
2011 Rudd ML, Price JC, Fogoros S, Godwin AK, Sgroi DC, Merino MJ, Bell DW. A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1331-40. PMID 21266528 DOI: 10.1158/1078-0432.CCR-10-0540  0.76
2011 Arnold JN, Saldova R, Galligan MC, Murphy TB, Mimura-Kimura Y, Telford JE, Godwin AK, Rudd PM. Novel glycan biomarkers for the detection of lung cancer. Journal of Proteome Research. 10: 1755-64. PMID 21214223 DOI: 10.1021/Pr101034T  0.76
2011 Ramus SJ, Kartsonaki C, Gayther SA, Pharoah PD, Sinilnikova OM, Beesley J, Chen X, McGuffog L, Healey S, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Manoukian S, Peissel B, ... ... Godwin A, et al. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. Journal of the National Cancer Institute. 103: 105-16. PMID 21169536 DOI: 10.1093/Jnci/Djq494  0.76
2011 Anderson KS, Sibani S, Wallstrom G, Qiu J, Mendoza EA, Raphael J, Hainsworth E, Montor WR, Wong J, Park JG, Lokko N, Logvinenko T, Ramachandran N, Godwin AK, Marks J, et al. Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer. Journal of Proteome Research. 10: 85-96. PMID 20977275 DOI: 10.1021/Pr100686B  0.76
2011 Zhang H, Kouadio A, Cartledge D, Godwin AK. Role of gamma-synuclein in microtubule regulation Experimental Cell Research. 317: 1330-1339. PMID 20974125 DOI: 10.1016/j.yexcr.2010.10.013  0.76
2011 Shoreibah MG, Jackson CL, Price PW, Meagher R, Godwin AK, Cai Q, Gildersleeve JC. Anti-human embryonic stem cell monoclonal antibody Hesca-2 binds to a glycan epitope commonly found on carcinomas. Stem Cells and Development. 20: 515-25. PMID 20887211 DOI: 10.1089/scd.2010.0172  0.76
2011 Nitta RT, Del Vecchio CA, Chu AH, Mitra SS, Godwin AK, Wong AJ. The role of the c-Jun N-terminal kinase 2-α-isoform in non-small cell lung carcinoma tumorigenesis. Oncogene. 30: 234-44. PMID 20871632 DOI: 10.1038/Onc.2010.414  0.76
2010 Li H, Cai Q, Godwin AK, Zhang R. Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells. Molecular Cancer Research : McR. 8: 1610-8. PMID 21115743 DOI: 10.1158/1541-7786.MCR-10-0398  0.76
2010 Walker LC, Fredericksen ZS, Wang X, Tarrell R, Pankratz VS, Lindor NM, Beesley J, Healey S, Chen X, Stoppa-Lyonnet D, Tirapo C, Giraud S, Mazoyer S, Muller D, ... ... Godwin AK, et al. Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers. Breast Cancer Research : Bcr. 12: R102. PMID 21114847 DOI: 10.1186/Bcr2785  0.76
2010 Capo-Chichi CD, Smedberg JL, Rula M, Nicolas E, Yeung AT, Adamo RF, Frolov A, Godwin AK, Xu XX. Alteration of Differentiation Potentials by Modulating GATA Transcription Factors in Murine Embryonic Stem Cells. Stem Cells International. 2010: 602068. PMID 21048850 DOI: 10.4061/2010/602068  0.76
2010 Tan Y, Cheung M, Pei J, Menges CW, Godwin AK, Testa JR. Upregulation of DLX5 promotes ovarian cancer cell proliferation by enhancing IRS-2-AKT signaling. Cancer Research. 70: 9197-206. PMID 21045156 DOI: 10.1158/0008-5472.CAN-10-1568  0.76
2010 Engel C, Versmold B, Wappenschmidt B, Simard J, Easton DF, Peock S, Cook M, Oliver C, Frost D, Mayes R, Evans DG, Eeles R, Paterson J, Brewer C, ... ... Godwin AK, et al. Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 2859-68. PMID 20978178 DOI: 10.1158/1055-9965.Epi-10-0517  0.76
2010 Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC, Kjaer SK, Birrer MJ, Berchuck A, Schildkraut J, Tomlinson I, Kiemeney LA, ... ... Godwin AK, et al. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nature Genetics. 42: 874-9. PMID 20852632 DOI: 10.1038/Ng.668  0.76
2010 Cordero AB, Kwon Y, Hua X, Godwin AK. In vivo imaging and therapeutic treatments in an orthotopic mouse model of ovarian cancer. Journal of Visualized Experiments : Jove. PMID 20811322 DOI: 10.3791/2125  0.76
2010 Ratner E, Lu L, Boeke M, Barnett R, Nallur S, Chin LJ, Pelletier C, Blitzblau R, Tassi R, Paranjape T, Hui P, Godwin AK, Yu H, Risch H, Rutherford T, et al. A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk. Cancer Research. 70: 6509-15. PMID 20647319 DOI: 10.1158/0008-5472.Can-10-0689  0.76
2010 Bernardo GM, Lozada KL, Miedler JD, Harburg G, Hewitt SC, Mosley JD, Godwin AK, Korach KS, Visvader JE, Kaestner KH, Abdul-Karim FW, Montano MM, Keri RA. FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis. Development (Cambridge, England). 137: 2045-54. PMID 20501593 DOI: 10.1242/Dev.043299  0.76
2010 Choi YL, Bocanegra M, Kwon MJ, Shin YK, Nam SJ, Yang JH, Kao J, Godwin AK, Pollack JR. LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer. Cancer Research. 70: 2296-306. PMID 20215510 DOI: 10.1158/0008-5472.Can-09-3141  0.76
2010 Smith ER, Cai KQ, Smedberg JL, Ribeiro MM, Rula ME, Slater C, Godwin AK, Xu XX. Nuclear Entry of Activated MAPK Is Restricted in Primary Ovarian and Mammary Epithelial Cells Plos One. 5. PMID 20174585 DOI: 10.1371/Journal.Pone.0009295  0.76
2010 Kamat AA, Baldwin M, Urbauer D, Dang D, Han LY, Godwin A, Karlan BY, Simpson JL, Gershenson DM, Coleman RL, Bischoff FZ, Sood AK. Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker. Cancer. 116: 1918-25. PMID 20166213 DOI: 10.1002/Cncr.24997  0.76
2010 Corney DC, Hwang CI, Matoso A, Vogt M, Flesken-Nikitin A, Godwin AK, Kamat AA, Sood AK, Ellenson LH, Hermeking H, Nikitin AY. Frequent downregulation of miR-34 family in human ovarian cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 1119-28. PMID 20145172 DOI: 10.1158/1078-0432.Ccr-09-2642  0.76
2010 Bellacosa A, Godwin AK, Peri S, Devarajan K, Caretti E, Vanderveer L, Bove B, Slater C, Zhou Y, Daly M, Howard S, Campbell KS, Nicolas E, Yeung AT, Clapper ML, et al. Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations. Cancer Prevention Research (Philadelphia, Pa.). 3: 48-61. PMID 20051372 DOI: 10.1158/1940-6207.Capr-09-0078  0.76
2010 Bendoraite A, Knouf EC, Garg KS, Parkin RK, Kroh EM, O'Briant KC, Ventura AP, Godwin AK, Karlan BY, Drescher CW, Urban N, Knudsen BS, Tewari M. Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition. Gynecologic Oncology. 116: 117-25. PMID 19854497 DOI: 10.1016/J.Ygyno.2009.08.009  0.76
2009 Osorio A, Milne RL, Pita G, Peterlongo P, Heikkinen T, Simard J, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Healey S, Neuhausen SL, Ding YC, Couch FJ, ... ... Godwin AK, et al. Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). British Journal of Cancer. 101: 2048-54. PMID 19920816 DOI: 10.1038/Sj.Bjc.6605416  0.76
2009 Ochs MF, Rink L, Tarn C, Mburu S, Taguchi T, Eisenberg B, Godwin AK. Detection of treatment-induced changes in signaling pathways in gastrointestinal stromal tumors using transcriptomic data Cancer Research. 69: 9125-9132. PMID 19903850 DOI: 10.1158/0008-5472.Can-09-1709  0.76
2009 Dupart JJ, Trent JC, Lee HY, Hess KR, Godwin AK, Taguchi T, Zhang W. Insulin-like growth factor binding protein-3 has dual effects on gastrointestinal stromal tumor cell viability and sensitivity to the anti-tumor effects of imatinib mesylate in vitro. Molecular Cancer. 8: 99. PMID 19903356 DOI: 10.1186/1476-4598-8-99  0.76
2009 Neuhausen SL, Brummel S, Ding YC, Singer CF, Pfeiler G, Lynch HT, Nathanson KL, Rebbeck TR, Garber JE, Couch F, Weitzel J, Narod SA, Ganz PA, Daly MB, Godwin AK, et al. Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers. Breast Cancer Research : Bcr. 11: R76. PMID 19843326 DOI: 10.1186/Bcr2414  0.76
2009 Dorgan JF, Stanczyk FZ, Egleston BL, Kahle LL, Shaw CM, Spittle CS, Godwin AK, Brinton LA. Prospective case-control study of serum mullerian inhibiting substance and breast cancer risk. Journal of the National Cancer Institute. 101: 1501-9. PMID 19820206 DOI: 10.1093/Jnci/Djp331  0.76
2009 Barker SD, Bale S, Booker J, Buller A, Das S, Friedman K, Godwin AK, Grody WW, Highsmith E, Kant JA, Lyon E, Mao R, Monaghan KG, Payne DA, Pratt VM, et al. Development and characterization of reference materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 genetic testing. The Journal of Molecular Diagnostics : Jmd. 11: 553-61. PMID 19767587 DOI: 10.2353/Jmoldx.2009.090078  0.76
2009 Rink L, Skorobogatko Y, Kossenkov AV, Belinsky MG, Pajak T, Heinrich MC, Blanke CD, von Mehren M, Ochs MF, Eisenberg B, Godwin AK. Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor. Molecular Cancer Therapeutics. 8: 2172-82. PMID 19671739 DOI: 10.1158/1535-7163.Mct-09-0193  0.76
2009 Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H, Heikkinen T, Simard J, Spurdle AB, Beesley J, Chen X, Neuhausen SL, Ding YC, Couch FJ, Wang X, ... ... Godwin AK, et al. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Human Molecular Genetics. 18: 4442-56. PMID 19656774 DOI: 10.1093/Hmg/Ddp372  0.76
2009 Cai KQ, Caslini C, Capo-Chichi CD, Slater C, Smith ER, Wu H, Klein-Szanto AJ, Godwin AK, Xu XX. Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia Plos One. 4. PMID 19649254 DOI: 10.1371/Journal.Pone.0006454  0.76
2009 Belinsky MG, Skorobogatko YV, Rink L, Pei J, Cai KQ, Vanderveer LA, Riddell D, Merkel E, Tarn C, Eisenberg BL, von Mehren M, Testa JR, Godwin AK. High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors. Genes, Chromosomes & Cancer. 48: 886-96. PMID 19585585 DOI: 10.1002/Gcc.20689  0.76
2009 Capo-chichi CD, Cai KQ, Testa JR, Godwin AK, Xu XX. Loss of GATA6 leads to nuclear deformation and aneuploidy in ovarian cancer Molecular and Cellular Biology. 29: 4766-4777. PMID 19581290 DOI: 10.1128/Mcb.00087-09  0.76
2009 Rink L, Godwin AK. Clinical and molecular characteristics of gastrointestinal stromal tumors in the pediatric and young adult population Current Oncology Reports. 11: 314-321. PMID 19508837 DOI: 10.1007/S11912-009-0044-0  0.76
2009 Levina VV, Nolen B, Su Y, Godwin AK, Fishman D, Liu J, Mor G, Maxwell LG, Herberman RB, Szczepanski MJ, Szajnik ME, Gorelik E, Lokshin AE. Biological significance of prolactin in gynecologic cancers. Cancer Research. 69: 5226-33. PMID 19491263 DOI: 10.1158/0008-5472.Can-08-4652  0.76
2009 Kanetsky PA, Mitra N, Vardhanabhuti S, Li M, Vaughn DJ, Letrero R, Ciosek SL, Doody DR, Smith LM, Weaver J, Albano A, Chen C, Starr JR, Rader DJ, Godwin AK, et al. Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nature Genetics. 41: 811-5. PMID 19483682 DOI: 10.1038/Ng.393  0.76
2009 Wyman SK, Parkin RK, Mitchell PS, Fritz BR, O'Briant K, Godwin AK, Urban N, Drescher CW, Knudsen BS, Tewari M. Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. Plos One. 4: e5311. PMID 19390579 DOI: 10.1371/Journal.Pone.0005311  0.76
2009 Lynch HT, Casey MJ, Snyder CL, Bewtra C, Lynch JF, Butts M, Godwin AK. Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management. Molecular Oncology. 3: 97-137. PMID 19383374 DOI: 10.1016/J.Molonc.2009.02.004  0.76
2009 Schilder RJ, Pathak HB, Lokshin AE, Holloway RW, Alvarez RD, Aghajanian C, Min H, Devarajan K, Ross E, Drescher CW, Godwin AK. Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash. Gynecologic Oncology. 113: 21-7. PMID 19162309 DOI: 10.1200/Jco.2007.25.18_Suppl.5577  0.76
2009 Howard JH, Frolov A, Tzeng CW, Stewart A, Midzak A, Majmundar A, Godwin A, Heslin M, Bellacosa A, Arnoletti JP. Epigenetic downregulation of the DNA repair gene MED1/MBD4 in colorectal and ovarian cancer. Cancer Biology & Therapy. 8: 94-100. PMID 19127118 DOI: 10.4161/Cbt.8.1.7469  0.76
2009 Sarkar D, Parkin R, Wyman S, Bendoraite A, Sather C, Delrow J, Godwin AK, Drescher C, Huber W, Gentleman R, Tewari M. Quality assessment and data analysis for microRNA expression arrays Nucleic Acids Research. 37. PMID 19103660 DOI: 10.1093/Nar/Gkn932  0.76
2009 Tuck MK, Chan DW, Chia D, Godwin AK, Grizzle WE, Krueger KE, Rom W, Sanda M, Sorbara L, Stass S, Wang W, Brenner DE. Standard operating procedures for serum and plasma collection: Early detection research network consensus statement standard operating procedure integration working group Journal of Proteome Research. 8: 113-117. PMID 19072545 DOI: 10.1021/Pr800545Q  0.76
2009 Bui CT, Nicolas E, Sallmann G, Chiotis M, Lambrinakos A, Rees K, Trounce I, Cotton RGH, Blakesley L, Godwin AK, Yeung AT. Enzymatic and Chemical Cleavage Methods to Identify Genetic Variation Molecular Diagnostics: Second Edition. 29-44. DOI: 10.1016/B978-0-12-374537-8.00003-1  0.76
2008 Patel BB, He YA, Li XM, Frolov A, Vanderveer L, Slater C, Schilder RJ, von Mehren M, Godwin AK, Yeung AT. Molecular mechanisms of action of imatinib mesylate in human ovarian cancer: a proteomic analysis. Cancer Genomics & Proteomics. 5: 137-49. PMID 18820368  0.76
2008 Belinsky MG, Rink L, Cai KQ, Ochs MF, Eisenberg B, Huang M, Von Mehren M, Godwin AK. The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors Cell Cycle. 7: 2949-2955. PMID 18818517 DOI: 10.4161/Cc.7.19.6760  0.76
2008 Tarn C, Rink L, Merkel E, Flieder D, Pathak H, Koumbi D, Testa JR, Eisenberg B, von Mehren M, Godwin AK. Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors. Proceedings of the National Academy of Sciences of the United States of America. 105: 8387-92. PMID 18550829 DOI: 10.1073/pnas.0803383105  0.76
2008 Quiros RM, Valianou M, Kwon Y, Brown KM, Godwin AK, Cukierman E. Ovarian normal and tumor-associated fibroblasts retain in vivo stromal characteristics in a 3-D matrix-dependent manner. Gynecologic Oncology. 110: 99-109. PMID 18448156 DOI: 10.1016/J.Ygyno.2008.03.006  0.76
2008 Fang CY, Miller SM, Bovbjerg DH, Bergman C, Edelson MI, Rosenblum NG, Bove BA, Godwin AK, Campbell DE, Douglas SD. Perceived stress is associated with impaired T-cell response to HPV16 in women with cervical dysplasia. Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. 35: 87-96. PMID 18347908 DOI: 10.1007/S12160-007-9007-6  0.76
2008 Zecchini S, Bianchi M, Colombo N, Fasani R, Goisis G, Casadio C, Viale G, Liu J, Herlyn M, Godwin AK, Nuciforo PG, Cavallaro U. The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium Cancer Research. 68: 1110-1118. PMID 18281486 DOI: 10.1158/0008-5472.Can-07-2897  0.76
2008 Potapova A, Hoffman AM, Godwin AK, Al-Saleem T, Cairns P. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer Cancer Research. 68: 998-1002. PMID 18281473 DOI: 10.1158/0008-5472.Can-07-2418  0.76
2008 Chen X, Weaver J, Bove BA, Vanderveer LA, Weil SC, Miron A, Daly MB, Godwin AK. Allelic imbalance in BRCA1 and BRCA2 gene expression is associated with an increased breast cancer risk Human Molecular Genetics. 17: 1336-1348. PMID 18204050 DOI: 10.1093/hmg/ddn022  0.76
2008 Liang M, Ayanga B, Du S, Godwin AK, Hartsock JK, Evans SC. Ovca1, a candidate gene of the genetic modifier of Tp53, Mop2, affects mouse embryonic lethality Genes Chromosomes and Cancer. 47: 315-325. PMID 18181179 DOI: 10.1002/Gcc.20535  0.76
2007 Antoniou AC, Sinilnikova OM, Simard J, Léoné M, Dumont M, Neuhausen SL, Struewing JP, Stoppa-Lyonnet D, Barjhoux L, Hughes DJ, Coupier I, Belotti M, Lasset C, Bonadona V, Bignon YJ, ... ... Godwin A, et al. RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. American Journal of Human Genetics. 81: 1186-200. PMID 17999359 DOI: 10.1086/522611  0.76
2007 Murph M, Tanaka T, Pang J, Felix E, Liu S, Trost R, Godwin AK, Newman R, Mills G. Liquid Chromatography Mass Spectrometry for Quantifying Plasma Lysophospholipids: Potential Biomarkers for Cancer Diagnosis Methods in Enzymology. 433: 1-25. PMID 17954226 DOI: 10.1016/S0076-6879(07)33001-2  0.76
2007 Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Research. 67: 8433-8. PMID 17823410 DOI: 10.1158/0008-5472.Can-07-1585  0.76
2007 Bell DW, Kim SH, Godwin AK, Schiripo TA, Harris PL, Haserlat SM, Wahrer DC, Haiman CA, Daly MB, Niendorf KB, Smith MR, Sgroi DC, Garber JE, Olopade OI, Le Marchand L, et al. Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts. International Journal of Cancer. Journal International Du Cancer. 121: 2661-7. PMID 17721994 DOI: 10.1002/Ijc.23026  0.76
2007 Khambata-Ford S, Garrett CR, Meropol NJ, Basik M, Harbison CT, Wu S, Wong TW, Huang X, Takimoto CH, Godwin AK, Tan BR, Krishnamurthi SS, Burris HA, Poplin EA, Hidalgo M, et al. Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 3230-7. PMID 17664471 DOI: 10.1200/JCO.2006.10.5437  0.76
2007 Page RE, Klein-Szanto AJ, Litwin S, Nicolas E, Al-Jumaily R, Alexander P, Godwin AK, Ross EA, Schilder RJ, Bassi DE. Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancer. Cellular Oncology : the Official Journal of the International Society For Cellular Oncology. 29: 289-99. PMID 17641413  0.76
2007 Couch FJ, Sinilnikova O, Vierkant RA, Pankratz VS, Fredericksen ZS, Stoppa-Lyonnet D, Coupier I, Hughes D, Hardouin A, Berthet P, Peock S, Cook M, Baynes C, Hodgson S, Morrison PJ, ... ... Godwin AK, et al. AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1416-21. PMID 17627006 DOI: 10.1158/1055-9965.EPI-07-0129  0.76
2007 Posadas EM, Liel MS, Kwitkowski V, Minasian L, Godwin AK, Hussain MM, Espina V, Wood BJ, Steinberg SM, Kohn EC. A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer. Cancer. 109: 1323-30. PMID 17330838 DOI: 10.1002/Cncr.22545  0.76
2007 Li H, Cherukuri P, Li N, Cowling V, Spinella M, Cole M, Godwin AK, Wells W, DiRenzo J. Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. Cancer Research. 67: 501-10. PMID 17234757 DOI: 10.1158/0008-5472.Can-05-4571  0.76
2007 Cai KQ, Yang WL, Capo-Chichi CD, Vanderveer L, Wu H, Godwin AK, Xu XX. Prominent expression of metalloproteinases in early stages of ovarian tumorigenesis Molecular Carcinogenesis. 46: 130-143. PMID 17131304 DOI: 10.1002/Mc.20273  0.76
2006 Tarn C, Godwin AK. The molecular pathogenesis of gastrointestinal stromal tumors Clinical Colorectal Cancer. 6. PMID 17101067 DOI: 10.3816/Ccc.2006.S.002  0.76
2006 Petrocca F, Iliopoulos D, Qin HR, Nicoloso MS, Yendamuri S, Wojcik SE, Shimizu M, Di Leva G, Vecchione A, Trapasso F, Godwin AK, Negrini M, Calin GA, Croce CM. Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer. Cancer Research. 66: 10287-91. PMID 17079447 DOI: 10.1158/0008-5472.Can-06-2289  0.76
2006 Pan ZZ, Bruening W, Godwin AK. Involvement of RHO GTPases and ERK in synuclein-gamma enhanced cancer cell motility. International Journal of Oncology. 29: 1201-5. PMID 17016652  0.76
2006 Tarn C, Skorobogatko YV, Taguchi T, Eisenberg B, von Mehren M, Godwin AK. Therapeutic effect of imatinib in gastrointestinal stromal tumors: AKT signaling dependent and independent mechanisms. Cancer Research. 66: 5477-86. PMID 16707477 DOI: 10.1158/0008-5472.CAN-05-3906  0.76
2006 Chen X, Arciero CA, Wang C, Broccoli D, Godwin AK. BRCC36 is essential for ionizing radiation-induced BRCA1 phosphorylation and nuclear foci formation. Cancer Research. 66: 5039-46. PMID 16707425 DOI: 10.1158/0008-5472.CAN-05-4194  0.76
2006 Cai KQ, Klein-Szanto A, Karthik D, Edelson M, Daly MB, Ozols RF, Lynch HT, Godwin AK, Xu XX. Age-dependent morphological alterations of human ovaries from populations with and without BRCA mutations. Gynecologic Oncology. 103: 719-28. PMID 16698071 DOI: 10.1016/J.Ygyno.2006.03.053  0.76
2006 Chen X, Truong TT, Weaver J, Bove BA, Cattie K, Armstrong BA, Daly MB, Godwin AK. Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression. Human Mutation. 27: 427-35. PMID 16619214 DOI: 10.1002/Humu.20319  0.76
2006 He F, Fenner BJ, Godwin AK, Kwang J. White spot syndrome virus open reading frame 222 encodes a viral E3 ligase and mediates degradation of a host tumor suppressor via ubiquitination Journal of Virology. 80: 3884-3892. PMID 16571805 DOI: 10.1128/Jvi.80.8.3884-3892.2006  0.76
2006 Prowse AH, Manek S, Varma R, Liu J, Godwin AK, Maher ER, Tomlinson IPM, Kennedy SH. Molecular genetic evidence that endometriosis is a precursor of ovarian cancer International Journal of Cancer. 119: 556-562. PMID 16506222 DOI: 10.1002/Ijc.21845  0.76
2006 Chen X, Arciero CA, Godwin AK. BRCA1-asscociated complexes: New targets to overcome breast cancer radiation resistance Expert Review of Anticancer Therapy. 6: 187-196. PMID 16445371 DOI: 10.1586/14737140.6.2.187  0.76
2006 Azizi AA, Gelpi E, Yang JW, Rupp B, Godwin AK, Slater C, Slavc I, Lubec G. Mass spectrometric identification of serine hydrolase OVCA2 in the medulloblastoma cell line DAOY Cancer Letters. 241: 235-249. PMID 16368187 DOI: 10.1016/J.Canlet.2005.10.023  0.76
2006 Colilla S, Kantoff PW, Neuhausen SL, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Brown M, Weber BL, Rebbeck TR. The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers. Carcinogenesis. 27: 599-605. PMID 16244359 DOI: 10.1093/Carcin/Bgi246  0.76
2005 Tarn C, Godwin AK. Molecular research directions in the management of gastrointestinal stromal tumors Current Treatment Options in Oncology. 6: 473-486. PMID 16242052 DOI: 10.1007/S11864-005-0026-X  0.76
2005 Capo-Chichi CD, Rula ME, Smedberg JL, Vanderveer L, Parmacek MS, Morrisey EE, Godwin AK, Xu XX. Perception of differentiation cues by GATA factors in primitive endoderm lineage determination of mouse embryonic stem cells. Developmental Biology. 286: 574-86. PMID 16162334 DOI: 10.1016/J.Ydbio.2005.07.037  0.76
2005 Miller SM, Roussi P, Daly MB, Buzaglo JS, Sherman K, Godwin AK, Balshem A, Atchison ME. Enhanced counseling for women undergoing BRCA1/2 testing: Impact on subsequent decision making about risk reduction behaviors Health Education and Behavior. 32: 654-667. PMID 16148211 DOI: 10.1177/1090198105278758  0.76
2005 Schilder RJ, Sill MW, Chen X, Darcy KM, Decesare SL, Lewandowski G, Lee RB, Arciero CA, Wu H, Godwin AK. Phase II study of gefitinib in patients with relapsed or persistent ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor mutations and immunohistochemical expression: a Gynecologic Oncology Group Study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 5539-48. PMID 16061871 DOI: 10.1158/1078-0432.Ccr-05-0462  0.76
2005 Yang WL, Roland IH, Godwin AK, Xu XX. Loss of TNF-α-regulated COX-2 expression in ovarian cancer cells Oncogene. 24: 7991-8002. PMID 16044148 DOI: 10.1038/Sj.Onc.1208943  0.76
2005 Tarn C, Merkel E, Canutescu AA, Shen W, Skorobogatko Y, Heslin MJ, Eisenberg B, Birbe R, Patchefsky A, Dunbrack R, Arnoletti JP, von Mehren M, Godwin AK. Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 3668-77. PMID 15897563 DOI: 10.1158/1078-0432.Ccr-04-2515  0.76
2005 Guo S, Hakimi MA, Baillat D, Chen X, Farber MJ, Klein-Szanto AJ, Cooch NS, Godwin AK, Shiekhattar R. Linking transcriptional elongation and messenger RNA export to metastatic breast cancers. Cancer Research. 65: 3011-6. PMID 15833825 DOI: 10.1158/0008-5472.Can-04-3624  0.76
2005 Smith-Beckerman DM, Fung KW, Williams KE, Auersperg N, Godwin AK, Burlingame AL. Proteome changes in ovarian epithelial cells derived from women with BRCA1 mutations and family histories of cancer. Molecular & Cellular Proteomics : McP. 4: 156-68. PMID 15591324 DOI: 10.1074/Mcp.M400157-Mcp200  0.76
2004 Stoyanova R, Clapper ML, Bellacosa A, Henske EP, Testa JR, Ross EA, Yeung AT, Nicolas E, Tsichlis N, Li YS, Linehan WM, Howard S, Campbell KS, Godwin AK, Boman BM, et al. Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutations. Cancer Biology & Therapy. 3: 1313-21. PMID 15662135 DOI: 10.4161/Cbt.3.12.1459  0.76
2004 Altomare DA, Hui QW, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK, Testa JR. AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth Oncogene. 23: 5853-5857. PMID 15208673 DOI: 10.1038/sj.onc.1207721  0.76
2004 Pinte S, Guérardel C, Deltour-Balerdi S, Godwin AK, Leprince D. Identification of a second G-C-rich promoter conserved in the human, murine and rat tumor suppressor genes HIC1 Oncogene. 23: 4023-4031. PMID 15007385 DOI: 10.1038/Sj.Onc.1207504  0.76
2004 Yang WL, Godwin AK, Xu XX. Tumor Necrosis Factor-α-Induced Matrix Proteolytic Enzyme Production and Basement Membrane Remodeling by Human Ovarian Surface Epithelial Cells: Molecular Basis Linking Ovulation and Cancer Risk Cancer Research. 64: 1534-1540. PMID 14973065 DOI: 10.1158/0008-5472.Can-03-2928  0.76
2004 Ozols RF, Bookman MA, Connolly DC, Daly MB, Godwin AK, Schilder RJ, Xu X, Hamilton TC. Focus on epithelial ovarian cancer Cancer Cell. 5: 19-24. PMID 14749123 DOI: 10.1016/S1535-6108(04)00002-9  0.76
2003 Roland IH, Yang WL, Yang DH, Daly MB, Ozols RF, Hamilton TC, Lynch HT, Godwin AK, Xu XX. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies. Cancer. 98: 2607-23. PMID 14669280 DOI: 10.1002/Cncr.11847  0.76
2003 Burrows JF, Chanduloy S, McIlhatton MA, Nagar H, Yeates K, Donaghy P, Price J, Godwin AK, Johnston PG, Russell SE. Altered expression of the septin gene, SEPT9, in ovarian neoplasia. The Journal of Pathology. 201: 581-8. PMID 14648661 DOI: 10.1002/Path.1484  0.76
2003 Dong Y, Hakimi MA, Chen X, Kumaraswamy E, Cooch NS, Godwin AK, Shiekhattar R. Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair. Molecular Cell. 12: 1087-99. PMID 14636569 DOI: 10.1016/S1097-2765(03)00424-6  0.76
2003 Martin ES, Cesari R, Pentimalli F, Yoder K, Fishel R, Himelstein AL, Martin SE, Godwin AK, Negrini M, Croce CM. The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene. Proceedings of the National Academy of Sciences of the United States of America. 100: 11517-22. PMID 14504409 DOI: 10.1073/Pnas.1934602100  0.76
2003 Capo-chichi CD, Roland IH, Vanderveer L, Bao R, Yamagata T, Hirai H, Cohen C, Hamilton TC, Godwin AK, Xu XX. Anomalous expression of epithelial differentiation-determining GATA factors in ovarian tumorigenesis. Cancer Research. 63: 4967-77. PMID 12941822  0.76
2003 Frolov A, Chahwan S, Ochs M, Arnoletti JP, Pan ZZ, Favorova O, Fletcher J, von Mehren M, Eisenberg B, Godwin AK. Response markers and the molecular mechanisms of action of Gleevec in gastrointestinal stromal tumors. Molecular Cancer Therapeutics. 2: 699-709. PMID 12939459  0.76
2003 Prowse AH, Schultz DC, Guo S, Vanderveer L, Dangel J, Bove B, Cairns P, Daly M, Godwin AK. Identification of a splice acceptor site mutation in p16INK4A/p14ARF within a breast cancer, melanoma, neurofibroma prone kindred. Journal of Medical Genetics. 40: e102. PMID 12920094 DOI: 10.1136/Jmg.40.8.E102  0.76
2003 Cesari R, Martin ES, Calin GA, Pentimalli F, Bichi R, McAdams H, Trapasso F, Drusco A, Shimizu M, Masciullo V, D'Andrilli G, Scambia G, Picchio MC, Alder H, Godwin AK, et al. Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27 Proceedings of the National Academy of Sciences of the United States of America. 100: 5956-5961. PMID 12719539 DOI: 10.1073/Pnas.0931262100  0.76
2003 Okamoto I, Kenyon LC, Emlet DR, Mori T, Sasaki J, Hirosako S, Ichikawa Y, Kishi H, Godwin AK, Yoshioka M, Suga M, Matsumoto M, Wong AJ. Expression of constitutively activated EGFRvIII in non-small cell lung cancer. Cancer Science. 94: 50-6. PMID 12708474 DOI: 10.1111/J.1349-7006.2003.Tb01351.X  0.76
2003 Costalas JW, Itzen M, Malick J, Babb JS, Bove B, Godwin AK, Daly MB. Communication of BRCA1 and BRCA2 results to at-risk relatives: A cancer risk assessment program's experience American Journal of Medical Genetics - Seminars in Medical Genetics. 119: 11-18. PMID 12704633  0.76
2003 Gupta A, Godwin AK, Vanderveer L, Lu A, Liu J. Hypomethylation of the Synuclein γ gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma Cancer Research. 63: 664-673. PMID 12566312  0.76
2003 Frolov AE, Godwin AK, Favorova OO. Differential gene expression analysis by DNA microarrays technology and its application in molecular oncology Molekulyarnaya Biologiya. 37: 573-584. DOI: 10.1023/A:1025166706481  0.76
2003 Frolov AE, Godwin AK, Favorova OO. Differential Gene Expression Analysis by DNA Microarray Technology and Its Application in Molecular Oncology Molecular Biology. 37: 486-494. DOI: 10.1023/A:1025166706481  0.76
2003 Ochs MF, Godwin AK. Microarrays in cancer: Research and applications: Introduction Biotechniques. 34.  0.76
2002 Capo-Chichi CD, Smith ER, Yang DH, Roland IH, Vanderveer L, Cohen C, Hamilton TC, Godwin AK, Xu XX. Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis. Cancer. 95: 1802-15. PMID 12365030 DOI: 10.1002/Cncr.10870  0.76
2002 Frolov A, Prowse AH, Vanderveer L, Bove B, Wu H, Godwin AK. DNA array-based method for detection of large rearrangements in the BRCA1 gene Genes Chromosomes and Cancer. 35: 232-241. PMID 12353265 DOI: 10.1002/Gcc.10109  0.76
2002 Smedberg JL, Smith ER, Capo-chichi CD, Frolov A, Yang DH, Godwin AK, Xu XX, Pa. Ras/MAPK pathway confers basement membrane dependence upon endoderm differentiation of embryonic carcinoma cells Journal of Biological Chemistry. 277: 40911-40918. PMID 12145292 DOI: 10.1074/Jbc.M205178200  0.76
2002 Antonyak MA, Kenyon LC, Godwin AK, James DC, Emlet DR, Okamoto I, Tnani M, Holgado-Madruga M, Moscatello DK, Wong AJ. Elevated JNK activation contributes to the pathogenesis of human brain tumors. Oncogene. 21: 5038-46. PMID 12140754 DOI: 10.1038/Sj.Onc.1205593  0.76
2002 Pan ZZ, Bruening W, Giasson BI, Lee VM, Godwin AK. Gamma-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways. The Journal of Biological Chemistry. 277: 35050-60. PMID 12121974 DOI: 10.1074/Jbc.M201650200  0.76
2002 Yang DH, Smith ER, Cohen C, Wu H, Patriotis C, Godwin AK, Hamilton TC, Xu XX. Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity Cancer. 94: 2380-2392. PMID 12015763 DOI: 10.1002/Cncr.10497  0.76
2002 Prowse AH, Vanderveer L, Milling SW, Pan ZZ, Dunbrack RL, Xu XX, Godwin AK. OVCA2 is downregulated and degraded during retinoid-induced apoptosis. International Journal of Cancer. Journal International Du Cancer. 99: 185-92. PMID 11979432 DOI: 10.1002/Ijc.10334  0.76
2002 Broccoli D, Godwin AK. Telomere length changes in human cancer. Methods in Molecular Medicine. 68: 271-8. PMID 11901508 DOI: 10.1385/1-59259-135-3:271  0.76
2002 Roberts D, Williams SJ, Cvetkovic D, Weinstein JK, Godwin AK, Johnson SW, Hamilton TC. Decreased expression of retinol-binding proteins is associated with malignant transformation of the ovarian surface epithelium. Dna and Cell Biology. 21: 11-9. PMID 11879576 DOI: 10.1089/10445490252810276  0.76
2002 Okamoto I, Tsuiki H, Kenyon LC, Godwin AK, Emlet DR, Holgado-Madruga M, Lanham IS, Joynes CJ, Vo KT, Guha A, Matsumoto M, Ushio Y, Saya H, Wong AJ. Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors. The American Journal of Pathology. 160: 441-7. PMID 11839564 DOI: 10.1016/S0002-9440(10)64863-8  0.76
2001 Esteller M, Fraga MF, Guo M, Garcia-Foncillas J, Hedenfalk I, Godwin AK, Trojan J, Vaurs-Barrière C, Bignon YJ, Ramus S, Benitez J, Caldes T, Akiyama Y, Yuasa Y, Launonen V, et al. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis Human Molecular Genetics. 10: 3001-3007. PMID 11751682 DOI: 10.1093/Hmg/10.26.3001  0.76
2001 Smith ER, Capo-chichi CD, He J, Smedberg JL, Yang DH, Prowse AH, Godwin AK, Hamilton TC, Xu XX. Disabled-2 mediates c-Fos suppression and the cell growth regulatory activity of retinoic acid in embryonic carcinoma cells. The Journal of Biological Chemistry. 276: 47303-10. PMID 11577091 DOI: 10.1074/Jbc.M106158200  0.76
2001 Guerardel C, Deltour S, Pinte S, Monte D, Begue A, Godwin AK, Leprince D. Identification in the Human Candidate Tumor Suppressor Gene HIC-1 of a New Major Alternative TATA-less Promoter Positively Regulated by p53 Journal of Biological Chemistry. 276: 3078-3089. PMID 11073960 DOI: 10.1074/Jbc.M008690200  0.76
2000 Grobelny JV, Godwin AK, Broccoli D. ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle. Journal of Cell Science. 113: 4577-85. PMID 11082050  0.76
2000 Salicioni AM, Xi M, Vanderveer LA, Balsara B, Testa JR, Dunbrack RL, Godwin AK. Identification and structural analysis of human RBM8A and RBM8B: Two highly conserved RNA-binding motif proteins that interact with OVCA1, a candidate tumor suppressor Genomics. 69: 54-62. PMID 11013075 DOI: 10.1006/Geno.2000.6315  0.76
2000 Kulinski J, Besack D, Oleykowski CA, Godwin AK, Yeung AT. CEL I enzymatic mutation detection assay Biotechniques. 29: 44-48. PMID 10907074 DOI: 10.2144/00291Bm07  0.76
2000 Bruening W, Giasson BI, Klein-Szanto AJ, Lee VM, Trojanowski JQ, Godwin AK. Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer. 88: 2154-63. PMID 10813729 DOI: 10.1002/(Sici)1097-0142(20000501)88:9<2154::Aid-Cncr23>3.0.Co;2-9  0.76
1999 Hirai H, Taguchi T, Godwin AK. Genomic differentiation of 18S ribosomal DNA and β-satellite DNA in the hominoid and its evolutionary aspects Chromosome Research. 7: 531-540. PMID 10598568 DOI: 10.1023/A:1009237412155  0.76
1999 Dangel J, Wagner-Costalas J, Bove B, Vanderveer L, Itzen M, Daly M, Godwin AK. Novel germline BRCA1 mutation (155del4) in an African American with early-onset breast cancer Human Mutation. 14: 545. PMID 10571958 DOI: 10.1002/(Sici)1098-1004(199912)14:6<545::Aid-Humu19>3.0.Co;2-G  0.76
1999 Riccio A, Aaltonen LA, Godwin AK, Loukola A, Percesepe A, Salovaara R, Masciullo V, Genuardi M, Paravatou-Petsotas M, Bassi DE, Ruggeri BA, Klein-Szanto AJ, Testa JR, Neri G, Bellacosa A. The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability. Nature Genetics. 23: 266-8. PMID 10545939 DOI: 10.1038/15443  0.56
1999 Bruening W, Prowse AH, Schultz DC, Holgado-Madruga M, Wong A, Godwin AK. Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells Cancer Research. 59: 4973-4983. PMID 10519411  0.76
1999 Wang-Gohrke S, Weikel W, Risch H, Vesprini D, Abrahamson J, Lerman C, Godwin A, Moslehi R, Olipade O, Brunet JS, Stickeler E, Kieback DG, Kreienberg R, Weber B, Narod SA, et al. Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations. British Journal of Cancer. 81: 179-83. PMID 10487631 DOI: 10.1038/sj.bjc.6690669  0.76
1999 Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, Isaacs C, Olopade O, Garber JE, Godwin AK, Daly MB, Narod SA, Neuhausen SL, Lynch HT, Weber BL. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. Journal of the National Cancer Institute. 91: 1475-9. PMID 10469748 DOI: 10.1093/Jnci/91.17.1475  0.76
1999 Kruk PA, Godwin AK, Hamilton TC, Auersperg N. Telomeric instability and reduced proliferative potential in ovarian surface epithelial cells from women with a family history of ovarian cancer Gynecologic Oncology. 73: 229-236. PMID 10329039 DOI: 10.1006/Gyno.1999.5348  0.76
1999 Abdollahi A, Getts LA, Sonoda G, Miller PD, Taguchi T, Godwin AK, Testa JR, Hamilton TC. Genome scanning detects amplification of the cathepsin B gene (CtsB) in transformed rat ovarian surface epithelial cells Journal of the Society For Gynecologic Investigation. 6: 32-40. PMID 10065424 DOI: 10.1016/S1071-5576(98)00048-3  0.76
1998 Schultz DC, Balasara BR, Testa JR, Godwin AK. Cloning and localization of a human diphthamide biosynthesis-like protein-2 gene, DPH2L2 Genomics. 52: 186-191. PMID 9782084 DOI: 10.1006/geno.1998.5420  0.76
1998 Oleykowski CA, Bronson Mullins CR, Godwin AK, Yeung AT. Mutation detection using a novel plant endonuclease Nucleic Acids Research. 26: 4597-4602. PMID 9753726 DOI: 10.1093/nar/26.20.4597  0.76
1998 Redston M, Nathanson KL, Yuan ZQ, Neuhausen SL, Satagopan J, Wong N, Yang D, Nafa D, Abrahamson J, Ozcelik H, Antin-Ozerkis D, Andrulis I, Daly M, Pinsky L, Schrag D, ... ... Godwin A, et al. The APCI1307K allele and breast cancer risk. Nature Genetics. 20: 13-4. PMID 9731522 DOI: 10.1038/1666  0.76
1998 Lynch HT, Casey MJ, Lynch J, White TEK, Godwin AK. Genetics and ovarian carcinoma Seminars in Oncology. 25: 265-280. PMID 9633840  0.76
1998 Hamilton TC, Johnson SW, Godwin AK. Molecular biology of gynecologic malignancies. Cancer Treatment and Research. 95: 103-14. PMID 9619281 DOI: 10.1007/978-1-4615-5447-9_2  0.76
1998 Brunet JS, Ghadirian P, Rebbeck TR, Lerman C, Garber JE, Tonin PN, Abrahamson J, Foulkes WD, Daly M, Wagner-Costalas J, Godwin A, Olopade OI, Moslehi R, Liede A, Futreal PA, et al. Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. Journal of the National Cancer Institute. 90: 761-6. PMID 9605646 DOI: 10.1093/Jnci/90.10.761  0.76
1997 Monaco C, Negrini M, Sozzi G, Veronese ML, Vorechovsky I, Godwin AK, Croce M C. Molecular cloning and characterization of LOH11CR2A, a new gene within a refined minimal region of LOH at 11q23 Genomics. 46: 217-222. PMID 9417908 DOI: 10.1006/Geno.1997.5036  0.76
1997 Sonoda G, Palazzo J, du Manoir S, Godwin AK, Feder M, Yakushiji M, Testa JR. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes, Chromosomes & Cancer. 20: 320-8. PMID 9408747 DOI: 10.1002/(Sici)1098-2264(199712)20:4<320::Aid-Gcc2>3.0.Co;2-3  0.76
1997 Petrukhin L, Dangel J, Vanderveer L, Costalas J, Bellacosa A, Grana G, Daly M, Godwin AK. The I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds Cancer Research. 57: 5480-5484. PMID 9407954  0.76
1997 Abdollahi A, Godwin AK, Miller PD, Getts LA, Schultz DC, Taguchi T, Testa JR, Hamilton TC. Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells Cancer Research. 57: 2029-2034. PMID 9158001  0.76
1997 Abdollahi A, Roberts D, Godwin AK, Schultz DC, Sonoda G, Testa JR, Hamilton TC. Identification of a zinc-finger gene at 6q25: A chromosomal region implicated in development of many solid tumors Oncogene. 14: 1973-1979. PMID 9150364 DOI: 10.1038/Sj.Onc.1201034  0.76
1997 Sonoda G, Du Manoir S, Godwin AK, Bell DW, Liu Z, Hogan M, Yakushiji M, Testa JR. Detection of DNA gains and losses in primary endometrial carcinomas by comparative genomic hybridization Genes Chromosomes and Cancer. 18: 115-125. PMID 9115961 DOI: 10.1002/(Sici)1098-2264(199702)18:2<115::Aid-Gcc6>3.0.Co;2-5  0.76
1997 Rebbeck TR, Walker AH, Phelan CM, Godwin AK, Buetow KH, Garber JE, Narod SA, Weber BL. Defining etiologic heterogeneity in breast cancer using genetic biomarkers. Progress in Clinical and Biological Research. 396: 53-61. PMID 9108589  0.76
1996 Dyck HG, Hamilton TC, Godwin AK, Lynch HT, Maines-Bandiera S, Auersperg N. Autonomy of the epithelial phenotype in human ovarian surface epithelium: Changes with neoplastic progression and with a family history of ovarian cancer International Journal of Cancer. 69: 429-436. PMID 8980241 DOI: 10.1002/(Sici)1097-0215(19961220)69:6<429::Aid-Ijc1>3.0.Co;2-6  0.76
1996 Salazar H, Godwin AK, Daly MB, Laub PB, Hogan WM, Rosenblum N, Boente MP, Lynch HT, Hamilton TC. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. Journal of the National Cancer Institute. 88: 1810-20. PMID 8961970 DOI: 10.1093/Jnci/88.24.1810  0.76
1996 Rebbeck TR, Godwin AK, Buetow KH. Variability in loss of constitutional heterozygosity across loci and among individuals: Association with candidate genes in ductal breast carcinoma Molecular Carcinogenesis. 17: 117-125. PMID 8944071 DOI: 10.1002/(Sici)1098-2744(199611)17:3<117::Aid-Mc3>3.0.Co;2-C  0.76
1996 Berman DB, Costalas J, Schultz DC, Grana G, Daly M, Godwin AK. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals. Cancer Research. 56: 3409-14. PMID 8758903  0.76
1996 Boente MP, Hamilton TC, Godwin AK, Buetow K, Kohler MF, Hogan WM, Berchuck A, Young RC. Early ovarian cancer: a review of its genetic and biologic factors, detection, and treatment. Current Problems in Cancer. 20: 83-137. PMID 8731031  0.76
1996 O'Dwyer PJ, Perez RP, Yao KS, Godwin AK, Hamilton TC. Increased DT-diaphorase expression and cross-resistance to mitomycin C in a series of cisplatin-resistant human ovarian cancer cell lines Biochemical Pharmacology. 52: 21-27. PMID 8678904 DOI: 10.1016/0006-2952(96)00131-1  0.76
1996 Berman DB, Wagner-Costalas J, Schultz DC, Lynch HT, Daly M, Godwin AK. Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds. American Journal of Human Genetics. 58: 1166-76. PMID 8651293  0.76
1996 Yao KS, Godwin AK, Johnson C, O'Dwyer PJ. Alternative splicing and differential expression of DT-diaphorase transcripts in human colon tumors and in peripheral mononuclear cells in response to mitomycin C treatment Cancer Research. 56: 1731-1736. PMID 8620484  0.76
1996 Schultz DC, Vanderveer L, Berman DB, Hamilton TC, Wong AJ, Godwin AK. Identification of two candidate tumor suppressor genes on chromosome 17p13.3. Cancer Research. 56: 1997-2002. PMID 8616839  0.76
1996 Schröder CP, Godwin AK, O'Dwyer PJ, Tew KD, Hamilton TC, Ozols RF. Glutathione and drug resistance Cancer Investigation. 14: 158-168. PMID 8597901 DOI: 10.3109/07357909609018891  0.76
1996 Holgado-Madruga M, Emlet DR, Moscatello DK, Godwin AK, Wong AJ. A Grb2-associated docking protein in EGF- and insulin-receptor signalling Nature. 379: 560-564. PMID 8596638 DOI: 10.1038/379560a0  0.76
1995 Schultz DC, Vanderveer L, Ozols RF, Hamilton TC, Godwin AK, Buetow KH, Boente MP. Characterization of Chromosome 9 in Human Ovarian Neoplasia Identifies Frequent Genetic Imbalance on 9q and Rare Alterations Involving 9p, Including CDKN2 Cancer Research. 55: 2150-2157. PMID 7743516  0.76
1995 Yao KS, Godwin AK, Johnson SW, Ozols RF, O'Dwyer PJ, Hamilton TC. Evidence for Altered Regulation of γ-Glutamylcysteine Synthetase Gene Expression among Cisplatin-sensitive and Cisplatin-resistant Human Ovarian Cancer Cell Lines Cancer Research. 55: 4367-4374. PMID 7671249  0.76
1995 Godwin AK, Miller PD, Getts LA, Jackson K, Sonoda G, Schray KJ, Testa JR, Hamilton TC. Retroviral-like sequences specifically expressed in the rat ovary detect genetic differences between normal and transformed rat ovarian surface epithelial cells. Endocrinology. 136: 4640-9. PMID 7664684 DOI: 10.1210/Endo.136.10.7664684  0.76
1995 Auersperg N, Maines-Bandiera S, Booth JH, Lynch HT, Godwin AK, Hamilton TC. Expression of two mucin antigens in cultured human ovarian surface epithelium: Influence of a family history of ovarian cancer American Journal of Obstetrics and Gynecology. 173: 558-565. PMID 7645635 DOI: 10.1016/0002-9378(95)90282-1  0.76
1995 Moscatello DK, Holgado-Madruga M, Godwin AK, Ramirez G, Gunn G, Zoltick PW, Biegel JA, Hayes RL, Wong AJ. Frequent Expression of a Mutant Epidermal Growth Factor Receptor in Multiple Human Tumors Cancer Research. 55: 5536-5539. PMID 7585629  0.76
1994 O'Dwyer PJ, Yao KS, Ford P, Godwin AK, Clayton M. Effects of Hypoxia on Detoxicating Enzyme Activity and Expression in HT29 Colon Adenocarcinoma Cells Cancer Research. 54: 3082-3087. PMID 8205521  0.76
1994 Testa JR, Getts LA, Salazar H, Liu Z, Handel LM, Godwin AK, Hamilton TC. Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity. Cancer Research. 54: 2778-84. PMID 8168110  0.76
1994 Johnson SW, Perez RP, Godwin AK, Yeung AT, Handel LM, Ozols RF, Hamilton TC. Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines Biochemical Pharmacology. 47: 689-697. PMID 8129746 DOI: 10.1016/0006-2952(94)90132-5  0.76
1994 Boente MP, Godwin AK, Hogan WM. Screening, imaging, and early diagnosis of ovarian cancer Clinical Obstetrics and Gynecology. 37: 377-391. PMID 8033450 DOI: 10.1097/00003081-199406000-00015  0.76
1994 Johnson SW, Swiggard PA, Handel LM, Brennan JM, Godwin AK, Ozols RF, Hamilton TC. Relationship between Platinum-DNA Adduct Formation and Removal and Cisplatin Cytotoxicity in Cisplatin-sensitive and -resistant Human Ovarian Cancer Cells Cancer Research. 54: 5911-5916. PMID 7954422  0.76
1993 Ranganathan S, Walsh ES, Godwin AK, Tew KD. Cloning and characterization of human colon glyoxalase-I Journal of Biological Chemistry. 268: 5661-5667. PMID 8449929  0.76
1993 Godwin AK, Testa JR, Hamilton TC. The biology of ovarian cancer development Cancer. 71: 530-536. PMID 8420673 DOI: 10.1002/Cncr.2820710207  0.76
1993 Perez RP, Godwin AK, Handel LM, Hamilton TC. A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines European Journal of Cancer. 29: 395-399. PMID 8398340 DOI: 10.1016/0959-8049(93)90394-U  0.76
1993 Perez RP, Hamaguchi K, Tracey PA, Handel LM, Hamilton TC, Godwin AK. Transformation of Rat Ovarian Epithelial and Rat-1 Fibroblast Cell Lines by RAST24 Does Not Influence Cisplatin Sensitivity Cancer Research. 53: 3771-3775. PMID 8339290  0.76
1993 Hamaguchi K, Godwin AK, Yakushyi M, O'Dwyer PJ, Ozols RF, Hamilton TC. Cross-Resistance to Diverse Drugs Is Associated with Primary Cisplatin Resistance in Ovarian Cancer Cell Lines Cancer Research. 53: 5225-5232. PMID 8106143  0.76
1993 Yao Ks, Godwin AK, Ozols RF, Hamilton TC, O'Dwyer PJ. Variable Baseline y-Glutamylcysteine Synthetase Messenger RNA Expression in Peripheral Mononuclear Cells of Cancer Patients, and Its Induction by Buthionine Sulfoximine Treatment Cancer Research. 53: 3662-3666. PMID 8101766  0.76
1992 Godwin AK, Testa JR, Handel LM, Liu Z, Vanderveer LA, Tracey PA, Hamilton TC. Spontaneous transformation of rat ovarian surface epithelial cells: Association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer Journal of the National Cancer Institute. 84: 592-601. PMID 1556770 DOI: 10.1093/Jnci/84.8.592  0.76
1992 Godwin AK, Perez RP, Johnson SW, Hamaguchi K, Hamilton TC. Growth regulation of ovarian cancer Hematology/Oncology Clinics of North America. 6: 829-841. PMID 1500388 DOI: 10.1016/S0889-8588(18)30312-5  0.76
1992 Cheng JQ, Godwin AK, Bellacosa A, Taguchi T, Franke TF, Hamilton TC, Tsichlis PN, Testa JR. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas Proceedings of the National Academy of Sciences of the United States of America. 89: 9267-9271. PMID 1409633 DOI: 10.1073/Pnas.89.19.9267  0.76
1992 Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC, Anderson ME. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis Proceedings of the National Academy of Sciences of the United States of America. 89: 3070-3074. PMID 1348364 DOI: 10.1073/Pnas.89.7.3070  0.76
1992 Habib GM, Rajagopalan S, Godwin AK, Lebovitz RM, Lieberman MW. The same gamma-glutamyl transpeptidase RNA species is expressed in fetal liver, hepatic carcinomas, and rasT24-transformed rat liver epithelial cells. Molecular Carcinogenesis. 5: 75-80. PMID 1347450  0.76
1991 Perez RP, Godwin AK, Hamilton TC, Ozols RF. Ovarian cancer biology Seminars in Oncology. 18: 186-204. PMID 2042060  0.76
1991 Speicher LA, Sheridan VR, Godwin AK, Tew KD. Resistance to the antimitotic drug estramustine is distinct from the multidrug resistant phenotype British Journal of Cancer. 64: 267-273. PMID 1892755 DOI: 10.1038/bjc.1991.290  0.76
1991 Godwin AK, Lieberman MW. Elevation of glucose transporter, c-myc, and transin RNA levels by Ha-rasT24 is independent of its effect on the cell cycle Molecular Carcinogenesis. 4: 275-285. PMID 1872950  0.76
1990 Godwin AK, Lieberman MW. Early and late responses to induction of rasT24 expression in Rat-1 cells Oncogene. 5: 1231-1241. PMID 2202952  0.76
1988 Seyama T, Godwin AK, DiPietro M, Winokur TS, Lebovitz RM, Lieberman MW. In vitro and in vivo regulation of liver epithelial cells carrying a metallothionein-rasT24 fusion gene. Molecular Carcinogenesis. 1: 89-95. PMID 3076453 DOI: 10.1002/Mc.2940010204  0.76
1988 Li YC, Seyama T, Godwin AK, Winokur TS, Lebovitz RM, Lieberman MW. MTrasT24, a metallothionein-ras fusion gene, modulates expression in cultured rat liver cells of two genes associated with in vivo liver cancer. Proceedings of the National Academy of Sciences of the United States of America. 85: 344-8. PMID 2893374 DOI: 10.1073/Pnas.85.2.344  0.76
1987 Reynolds VL, Lebovitz RM, Warren S, Hawley TS, Godwin AK, Lieberman MW. Regulation of a metallothionein-rasT24 fusion gene by zinc results in graded alterations in cell morphology and growth. Oncogene. 1: 323-30. PMID 3330778  0.76
1985 MacArthur CA, Ramabhadran R, Godwin AK, Lebovitz RM, Lieberman MW. Chemical carcinogens induce cadmium resistance and activate metallothionein genes in cadmium sensitive S49 mouse cells. Carcinogenesis. 6: 887-92. PMID 3874005 DOI: 10.1093/carcin/6.6.887  0.76
1985 MacArthur CA, Godwin AK, Lebovitz RM, Lieberman MW. Chemical carcinogens induce cadmium resistance and activate quiescent metallothionein genes Federation Proceedings. 44: 3011.  0.76
Show low-probability matches.